ROS1 and inflammatory myofibroblastic tumor: ROS1 oncogenic activation has been observed in patients with different tumor types such as glioblastoma, NSCLC, cholangiocarcinoma, gastric, ovarian and colon carcinoma, angiosarcoma and inflammatory myofibroblastic tumors (IMT) [12].